Hunter Gillies, CHIEF MEDICAL OFFICER at Aerovate Therapeutics, Inc. (AVTE), sold 21,897 shares at $19.50 ($427K) on 2023-12-14, disclosed to the SEC on 2023-12-15.
Scheduled sale ($427k) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.50 | 2,103 | $41K | 9.6% |
| 2 | $19.50 | 9,897 | $193K | 45.2% |
| 3 | $19.50 | 9,897 | $193K | 45.2% |
| Total | $19.50 avg | 21,897 | $427K | 100% |
| Filing → |
| AVTE | SELL | 2024-04-19 | $172K | — | Filing → |
| AVTE | SELL | 2024-04-01 | $266K | — | Filing → |
| AVTE | SELL | 2024-03-20 | $346K | — | Filing → |